PCR-Based Microarray Enhances Diagnosis of Culture-Negative Biopsied Tissue in Patients with Invasive Mold Infections: Real-World Experience in a Tertiary Medical Center
Authors:
- Hao-En JanHJHao-En Jan
- Chin-Shiang TsaiCTChin-Shiang Tsai
- Cong-Tat CiaCCCong-Tat Cia
- Ching-Chi LeeChing-Chi Lee
- Ying-Wen ChenYCYing-Wen Chen
- Nan-Yao LeeNLNan-Yao Lee
- Chia-Wen LiCLChia-Wen Li
- Ming-Chi LiMLMing-Chi Li
- Ling-Shan SyueLSLing-Shan Syue
- Ching-Lung LoCLChing-Lung Lo
- Tsung-Chain ChangTCTsung-Chain Chang
- Chi-Jung WuCWChi-Jung Wu
Open Access
- 29 July 2024
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (8) , 530
Abstract
A fungal polymerase chain reaction (PCR) amplifies conserved genes across diverse species, combined with the subsequent hybridization of amplicons using a specific oligonucleotide microarray, allowing for the rapid detection of pathogens at the species level. However, the performance of microarrays in diagnosing invasive mold infections (IMI) from infected tissue samples is rarely reported. During the 4-year study period, all biopsied tissue samples from patients with a suspected IMI sent for microarray assays were analyzed. A partial segment of the internal transcribed spacer (ITS) region was amplified by nested PCR after DNA extraction. Amplicons were hybridized with specific probes for a variety of mold species using an in-house oligonucleotide microarray. A total of 80 clinical samples from 74 patients were tested. A diagnosis of an IMI was made in 10 patients (4 proven, 1 probable, 3 possible, 2 clinical suspicion). The PCR/microarray test was positive for three out of four proven IMIs, one probable IMI, and one out of three possible IMIs. Two patients with positive PCR/microarray findings were considered to have clinical suspicion of an IMI, and their responsible physicians initiated antifungal therapy despite the absence of supporting microbiological and histological evidence. Clinical diagnoses were categorized into non-IMI and IMI groups (including proven, probable, possible, and clinical suspicion). The sensitivity and specificity of the microarray in diagnosing the IMIs were 70% and 95.7%, respectively, while the sensitivity and specificity of the culture and histological findings were 10%/96.3% and 40.0%/100%, respectively. PCR-based methods provide supportive microbiological evidence when culture results are inconclusive. The combination of a microarray with fungal culture and histology promotes the precise diagnosis of IMIs in difficult-to-diagnose patients.Keywords
Funding Information
- National Science and Technology Council, Taiwan (NSTC 113-2321-B-006-007-)
This publication has 39 references indexed in Scilit:
- Aspergillus InfectionsNew England Journal of Medicine, 2021
- Azole resistance survey on clinical Aspergillus fumigatus isolates in SpainClinical Microbiology and Infection, 2021
- A metagenomics-based diagnostic approach for central nervous system infections in hospital acute care settingScientific Reports, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Molecular diagnostics in medical mycologyNature Communications, 2018
- Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical PracticeClinical Infectious Diseases, 2018
- Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care NetworkOpen Forum Infectious Diseases, 2018
- Clinical use of fungal PCR from deep tissue samples in the diagnosis of invasive fungal diseases: a retrospective observational studyClinical Microbiology and Infection, 2018
- Catheter-related fungemia caused by Candida dubliniensisJournal of Microbiology, Immunology and Infection, 2013
- DNA microarrays for the diagnosis of infectious diseasesMedecine Et Maladies Infectieuses, 2012